ID   ZMIZ2_HUMAN             Reviewed;         920 AA.
AC   Q8NF64; A4D2K7; D3DVL1; O94790; Q0VGB4; Q659A8; Q6JKL5; Q8WTX8; Q96Q01;
AC   Q9BQH7;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 2.
DT   28-JUN-2023, entry version 167.
DE   RecName: Full=Zinc finger MIZ domain-containing protein 2;
DE   AltName: Full=PIAS-like protein Zimp7;
GN   Name=ZMIZ2; Synonyms=KIAA1886, ZIMP7; ORFNames=HRIHFB2007;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, INTERACTION WITH AR;
RP   SMARCA4 AND SMARCE1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16051670; DOI=10.1210/me.2005-0097;
RA   Huang C.-Y., Beliakoff J., Li X., Lee J., Li X., Sharma M., Lim B., Sun Z.;
RT   "hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated
RT   transcription and interacts with SWI/SNF-like BAF complexes.";
RL   Mol. Endocrinol. 19:2915-2929(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT PHE-408.
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 316-920 (ISOFORM 1).
RC   TISSUE=Kidney, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 240-920 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11572484; DOI=10.1093/dnares/8.4.179;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXI. The
RT   complete sequences of 60 new cDNA clones from brain which code for large
RT   proteins.";
RL   DNA Res. 8:179-187(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 332-920.
RC   TISSUE=Amygdala, and Fetal brain;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 668-920, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Fetal brain;
RX   PubMed=9853615; DOI=10.1038/4315;
RA   Ueki N., Oda T., Kondo M., Yano K., Noguchi T., Muramatsu M.-A.;
RT   "Selection system for genes encoding nuclear-targeted proteins.";
RL   Nat. Biotechnol. 16:1338-1342(1998).
RN   [10]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-245 AND ARG-262, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [11]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-402, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-402; LYS-457 AND LYS-692, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Increases ligand-dependent transcriptional activity of AR and
CC       other nuclear hormone receptors. {ECO:0000269|PubMed:16051670}.
CC   -!- SUBUNIT: Interacts with AR, SMARCA4/BRG1 and SMARCE1/BAF57. Interaction
CC       with either SMARCA4 and SMARCE1 enhances AR-mediated transcription.
CC       {ECO:0000269|PubMed:16051670}.
CC   -!- INTERACTION:
CC       Q8NF64; Q8N5N6: ARSJ; NbExp=3; IntAct=EBI-745786, EBI-10266832;
CC       Q8NF64; A0A0S2Z5G4: BANP; NbExp=3; IntAct=EBI-745786, EBI-16429704;
CC       Q8NF64; B4DE54: BANP; NbExp=3; IntAct=EBI-745786, EBI-16429313;
CC       Q8NF64; Q8N9N5-2: BANP; NbExp=3; IntAct=EBI-745786, EBI-11524452;
CC       Q8NF64; Q8N9N5-7: BANP; NbExp=3; IntAct=EBI-745786, EBI-16429296;
CC       Q8NF64; O75575: CRCP; NbExp=3; IntAct=EBI-745786, EBI-2654687;
CC       Q8NF64; O00629: KPNA4; NbExp=3; IntAct=EBI-745786, EBI-396343;
CC       Q8NF64; Q13526: PIN1; NbExp=4; IntAct=EBI-745786, EBI-714158;
CC       Q8NF64-2; Q8N5N6: ARSJ; NbExp=3; IntAct=EBI-10182121, EBI-10266832;
CC       Q8NF64-2; Q8WXK3: ASB13; NbExp=3; IntAct=EBI-10182121, EBI-707573;
CC       Q8NF64-2; Q8N9N5: BANP; NbExp=3; IntAct=EBI-10182121, EBI-744695;
CC       Q8NF64-2; Q9BSF0: C2orf88; NbExp=3; IntAct=EBI-10182121, EBI-744298;
CC       Q8NF64-2; O75575: CRCP; NbExp=3; IntAct=EBI-10182121, EBI-2654687;
CC       Q8NF64-2; Q96HW7: INTS4; NbExp=3; IntAct=EBI-10182121, EBI-5663129;
CC       Q8NF64-2; P41271: NBL1; NbExp=3; IntAct=EBI-10182121, EBI-10208650;
CC       Q8NF64-2; Q13526: PIN1; NbExp=3; IntAct=EBI-10182121, EBI-714158;
CC       Q8NF64-2; Q9Y467: SALL2; NbExp=3; IntAct=EBI-10182121, EBI-746180;
CC       Q8NF64-2; O15126: SCAMP1; NbExp=3; IntAct=EBI-10182121, EBI-954338;
CC       Q8NF64-2; P59797: SELENOV; NbExp=3; IntAct=EBI-10182121, EBI-10216195;
CC       Q8NF64-2; Q16385: SSX2B; NbExp=3; IntAct=EBI-10182121, EBI-2210673;
CC       Q8NF64-2; O75865: TRAPPC6A; NbExp=3; IntAct=EBI-10182121, EBI-743573;
CC       Q8NF64-2; A0A384ME25; NbExp=3; IntAct=EBI-10182121, EBI-10211777;
CC       Q8NF64-3; Q9UBL6-2: CPNE7; NbExp=3; IntAct=EBI-12011330, EBI-12012272;
CC       Q8NF64-3; O43559: FRS3; NbExp=3; IntAct=EBI-12011330, EBI-725515;
CC       Q8NF64-3; O75603: GCM2; NbExp=3; IntAct=EBI-12011330, EBI-10188645;
CC       Q8NF64-3; Q13526: PIN1; NbExp=3; IntAct=EBI-12011330, EBI-714158;
CC       Q8NF64-3; O75177-5: SS18L1; NbExp=3; IntAct=EBI-12011330, EBI-12035119;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16051670,
CC       ECO:0000269|PubMed:9853615}. Note=Detected at replication foci
CC       throughout S phase.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8NF64-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NF64-2; Sequence=VSP_012190;
CC       Name=3;
CC         IsoId=Q8NF64-3; Sequence=VSP_024918, VSP_012190;
CC   -!- TISSUE SPECIFICITY: Expressed most abundantly in testis with lower
CC       levels in heart, brain, pancreas, prostate and ovary.
CC       {ECO:0000269|PubMed:16051670}.
CC   -!- DOMAIN: The C-terminal proline-rich domain possesses a significant
CC       intrinsic transcriptional activity. This activity is inhibited by the
CC       N-terminus in the full-length protein.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH21924.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC03396.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAB66507.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY426594; AAR85526.1; -; mRNA.
DR   EMBL; AK090415; BAC03396.1; ALT_INIT; mRNA.
DR   EMBL; AC004859; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC013436; AAP22368.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH236960; EAL23750.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW61083.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW61084.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW61085.1; -; Genomic_DNA.
DR   EMBL; BC021924; AAH21924.1; ALT_INIT; mRNA.
DR   EMBL; BC110435; AAI10436.1; -; mRNA.
DR   EMBL; AB067473; BAB67779.1; -; mRNA.
DR   EMBL; AL831933; CAH56269.1; -; mRNA.
DR   EMBL; AL136572; CAB66507.1; ALT_INIT; mRNA.
DR   EMBL; AB015330; BAA34789.1; -; mRNA.
DR   CCDS; CCDS43576.1; -. [Q8NF64-1]
DR   CCDS; CCDS43577.1; -. [Q8NF64-2]
DR   CCDS; CCDS75591.1; -. [Q8NF64-3]
DR   RefSeq; NP_001287888.1; NM_001300959.1. [Q8NF64-3]
DR   RefSeq; NP_113637.3; NM_031449.3. [Q8NF64-1]
DR   RefSeq; NP_777589.2; NM_174929.2. [Q8NF64-2]
DR   RefSeq; XP_005249926.1; XM_005249869.2. [Q8NF64-1]
DR   RefSeq; XP_005249929.1; XM_005249872.2. [Q8NF64-2]
DR   AlphaFoldDB; Q8NF64; -.
DR   SMR; Q8NF64; -.
DR   BioGRID; 123701; 46.
DR   IntAct; Q8NF64; 35.
DR   STRING; 9606.ENSP00000311778; -.
DR   GlyGen; Q8NF64; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q8NF64; -.
DR   PhosphoSitePlus; Q8NF64; -.
DR   BioMuta; ZMIZ2; -.
DR   DMDM; 56404909; -.
DR   EPD; Q8NF64; -.
DR   jPOST; Q8NF64; -.
DR   MassIVE; Q8NF64; -.
DR   MaxQB; Q8NF64; -.
DR   PaxDb; Q8NF64; -.
DR   PeptideAtlas; Q8NF64; -.
DR   ProteomicsDB; 73263; -. [Q8NF64-1]
DR   ProteomicsDB; 73264; -. [Q8NF64-2]
DR   ProteomicsDB; 73265; -. [Q8NF64-3]
DR   Antibodypedia; 27318; 124 antibodies from 24 providers.
DR   DNASU; 83637; -.
DR   Ensembl; ENST00000265346.11; ENSP00000265346.7; ENSG00000122515.16. [Q8NF64-2]
DR   Ensembl; ENST00000309315.9; ENSP00000311778.4; ENSG00000122515.16. [Q8NF64-1]
DR   Ensembl; ENST00000413916.5; ENSP00000409648.1; ENSG00000122515.16. [Q8NF64-3]
DR   Ensembl; ENST00000441627.5; ENSP00000414723.1; ENSG00000122515.16. [Q8NF64-1]
DR   GeneID; 83637; -.
DR   KEGG; hsa:83637; -.
DR   MANE-Select; ENST00000309315.9; ENSP00000311778.4; NM_031449.4; NP_113637.3.
DR   UCSC; uc003tlq.4; human. [Q8NF64-1]
DR   AGR; HGNC:22229; -.
DR   CTD; 83637; -.
DR   DisGeNET; 83637; -.
DR   GeneCards; ZMIZ2; -.
DR   HGNC; HGNC:22229; ZMIZ2.
DR   HPA; ENSG00000122515; Low tissue specificity.
DR   MIM; 611196; gene.
DR   neXtProt; NX_Q8NF64; -.
DR   OpenTargets; ENSG00000122515; -.
DR   PharmGKB; PA162409851; -.
DR   VEuPathDB; HostDB:ENSG00000122515; -.
DR   eggNOG; KOG2169; Eukaryota.
DR   GeneTree; ENSGT01030000234539; -.
DR   HOGENOM; CLU_009461_1_0_1; -.
DR   InParanoid; Q8NF64; -.
DR   OrthoDB; 20246at2759; -.
DR   PhylomeDB; Q8NF64; -.
DR   TreeFam; TF316952; -.
DR   PathwayCommons; Q8NF64; -.
DR   SignaLink; Q8NF64; -.
DR   BioGRID-ORCS; 83637; 14 hits in 1176 CRISPR screens.
DR   ChiTaRS; ZMIZ2; human.
DR   GeneWiki; ZMIZ2; -.
DR   GenomeRNAi; 83637; -.
DR   Pharos; Q8NF64; Tbio.
DR   PRO; PR:Q8NF64; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q8NF64; protein.
DR   Bgee; ENSG00000122515; Expressed in endothelial cell and 195 other tissues.
DR   ExpressionAtlas; Q8NF64; baseline and differential.
DR   Genevisible; Q8NF64; HS.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0043596; C:nuclear replication fork; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030374; F:nuclear receptor coactivator activity; IDA:UniProtKB.
DR   GO; GO:0061665; F:SUMO ligase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0016925; P:protein sumoylation; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR004181; Znf_MIZ.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR10782; ZINC FINGER MIZ DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR10782:SF38; ZINC FINGER MIZ DOMAIN-CONTAINING PROTEIN 2; 1.
DR   Pfam; PF02891; zf-MIZ; 1.
DR   PROSITE; PS51044; ZF_SP_RING; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Isopeptide bond; Metal-binding; Methylation; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..920
FT                   /note="Zinc finger MIZ domain-containing protein 2"
FT                   /id="PRO_0000218989"
FT   ZN_FING         585..671
FT                   /note="SP-RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00452"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          54..79
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          243..265
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          286..391
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          435..506
FT                   /note="Interaction with AR"
FT                   /evidence="ECO:0000269|PubMed:16051670"
FT   REGION          803..920
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        292..306
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        332..363
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        364..383
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        839..853
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        903..920
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         616
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00452"
FT   BINDING         618
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00452"
FT   BINDING         639
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00452"
FT   BINDING         642
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00452"
FT   MOD_RES         111
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CIE2"
FT   MOD_RES         245
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         262
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   CROSSLNK        402
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25772364,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        457
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        692
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         56..87
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_024918"
FT   VAR_SEQ         334..359
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11572484,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:16051670"
FT                   /id="VSP_012190"
FT   VARIANT         408
FT                   /note="L -> F (in dbSNP:rs3735478)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_050536"
FT   CONFLICT        127
FT                   /note="Missing (in Ref. 1; AAR85526)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        462
FT                   /note="R -> RR (in Ref. 8; CAH56269)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        568
FT                   /note="Missing (in Ref. 1)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        765
FT                   /note="T -> M (in Ref. 1, 6 and 8; CAB66507)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        782
FT                   /note="S -> C (in Ref. 9)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        799
FT                   /note="A -> V (in Ref. 9)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   920 AA;  96537 MW;  C9CE99D0B0798B9F CRC64;
     MNSMNPMKPA LPPAPHGDGS FAYESVPWQQ SATQPAGSLS VVTTVWGVGN ATQSQVLGNP
     MGPAGSPSGS SMMPGVAGGS SALTSPQCLG QQAFAEGGAN KGYVQQGVYS RGGYPGAPGF
     TTGYAGGPGG LGLPSHAARP STDFTQAAAA AAVAAAAATA TATATATVAA LQEKQSQELS
     QYGAMGAGQS FNSQFLQHGG PRGPSVPAGM NPTGIGGVMG PSGLSPLAMN PTRAAGMTPL
     YAGQRLPQHG YPGPPQAQPL PRQGVKRTYS EVYPGQQYLQ GGQYAPSTAQ FAPSPGQPPA
     PSPSYPGHRL PLQQGMTQSL SVPGPTGLHY KPTEQFNGQG ASFNGGSVSY SQPGLSGPTR
     SIPGYPSSPL PGNPTPPMTP SSSVPYMSPN QEVKSPFLPD LKPNLNSLHS SPSGSGPCDE
     LRLTFPVRDG VVLEPFRLQH NLAVSNHVFQ LRDSVYKTLI MRPDLELQFK CYHHEDRQMN
     TNWPASVQVS VNATPLTIER GDNKTSHKPL YLKHVCQPGR NTIQITVTAC CCSHLFVLQL
     VHRPSVRSVL QGLLKKRLLP AEHCITKIKR NFSSGTIPGT PGPNGEDGVE QTAIKVSLKC
     PITFRRIQLP ARGHDCRHIQ CFDLESYLQL NCERGTWRCP VCNKTALLEG LEVDQYMLGI
     LIYIQNSDYE EITIDPTCSW KPVPVKPDMH IKEEPDGPAL KRCRTVSPAH VLMPSVMEMI
     AALGPGAAPF APLQPPSVPA PSDYPGQGSS FLGPGTFPES FPPTTPSTPT LAEFTPGPPP
     ISYQSDIPSS LLTSEKSTAC LPSQMAPAGH LDPTHNPGTP GLHTSNLGAP PGPQLHHSNP
     PPASRQSLGQ ASLGPTGELA FSPATGVMGP PSMSGAGEAP EPALDLLPEL TNPDELLSYL
     GPPDLPTNNN DDLLSLFENN
//
